|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2009-06-04 Option Award |
2009-06-08 1:08 pm | PDI INC | PDII | LUBATKIN VERONICA (Director) | 12,262 | $3.67 | $45,002 | 26,281 (Direct) | View |
| 2008-12-31 Tax Withholding |
2009-01-05 6:09 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LUBATKIN VERONICA (EVP, Chief Financial Officer) | 20,140 | $13.41 | $270,077 | 50,606 (Direct) |
View |
| 2008-12-22 Tax Withholding |
2008-12-23 3:50 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LUBATKIN VERONICA (EVP, Chief Financial Officer) | 1,355 | $12.43 | $16,843 | 70,746 (Direct) |
View |
| 2008-04-21 Tax Withholding |
2008-06-06 3:31 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LUBATKIN VERONICA (Exec VP and CFO) | 669 | $17.7 | $11,841 | 72,101 (Direct) |
View |
| 2008-03-24 Tax Withholding | 2008-03-26 3:52 pm |
PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LUBATKIN VERONICA (EVP and CFO) | 1,255 | $18.37 | $23,054 | 72,770 (Direct) | View |
| 2008-01-11 Option Award(A) | 2008-01-17 4:26 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LUBATKIN VERONICA (Exec VP, CFO) | 36,849 | $0 | $0 | 74,025 (Direct) |
View |
| 2008-01-11 Option Award |
2008-01-15 4:50 pm | PAR PHARMACEUTICAL COMPANIES, INC. | PRX | LUBATKIN VERONICA (Exec VP and CFO) | 36,849 | $0 | $0 | 69,639 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 19:17:15 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |